-
Fuller’s outperforms in a tough market – here's why it is worth buyingPub group Fuller’s continues to outperform despite headwinds in the hospitality sector. Should you buy its shares?
-
Will AI really wipe out all our jobs?How worried should we be about AI? Technological developments have always sparked fears of mass unemployment – but are those fears overdone?
-
High-quality and profitable companies in emerging marketsOpinion Three emerging market stocks, picked by Mark Hammonds, fund manager for the Guinness Emerging Markets Equity Income Fund
Opinion -
Biotech's future looks bright – the best investments to buyBiotechnology companies are coming out of a dark period for the industry. Why has the tide turned, and is now a good time to buy in?
-
Three AI stocks to watchDespite wobbles and overvaluation fears, the AI trade still dominates the stock market. Here are three of the most notable stocks in the sector.
-
High hopes for SpaceX as its lands on Nasdaq 100Early analyst opinions signal confidence in the long-term growth potential of the newly listed space exploration and AI business.
-
AI ETFs: should you buy one?Investment into artificial intelligence has surged but in some corners, concerns around hype, lofty valuations and asset bubbles remain. Is now the time to buy an AI ETF?
-
Constellation Energy: a smart play on the AI energy raceConstellation Energy is a compelling opportunity for investors looking to plug their portfolios into AI. Should you buy its shares?
-
Dr Douglas Williams: new drugs and AI will fuel the biotech boomHealthcare veteran Dr Douglas Williams on the effect on the biotech sector of US political upheaval, and the prospect of major new treatments
